GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders
BALTIMORE, July 05, 2023 -- Greater Cannabis Company, Inc. a publicly traded biopharmaceutical company pioneering development of next generation therapeutics is pleased to announce that it has...
United States Aitan Zacharin Adi Aran Israel Ministry Of Health Greater Cannabis Company Inc Exchange Commission
Source: marketscreener.com